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Abstract 
 
 QSAR study using the (PC-ANN) methodology was conducted to predict the inhibition 
constants of 127 symmetrical and unsymmetrical cyclic urea and cyclic cyanoguanidine 
derivatives containing different substituent groups such as: benzyl, isopropyl, 4-
hydroxybenzyl, ketone, oxime, pyrazole, imidazole, triazole and having anti-HIV-1 
protease activities. The results obtained by principal component-artificial neural network 
provided advanced regression models with good prediction ability. A 0.743 and 0.750 
coefficients of determination were obtained using principal component-artificial neural 
network. 
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  اﻟﻤﻠﺨﺺ
ﻟﻤﺠﻤﻮﻋѧﺔ ﻣѧﻦ  NNA-CP( )ﺑﺎﺳѧﺘﺨﺪام ﻃﺮﻳﻘѧﺔ   واﻟﺘﺮآﻴѧﺐ ﻓѧﻲ ﺛﻼﺛѧﺔ أﺑﻌѧﺎد  ﺑѧﻴﻦ اﻟﻔﺎﻋﻠﻴѧﺔ  اﻟﻜﻤﻴﺔ ﻟﻘﺪ ﺗﻤﺖ دراﺳﺔ اﻟﻌﻼﻗﺔ 
ﺗѧﺸﻤﻞ ﺗﻔﺮﻋѧﺎت ﺑﻨﺎﺋﻴѧﺔ ( )enidinaugonayc  وﻣѧﺸﺘﻘﺎت  )aeru cilcyc(  ﻣﺮآѧﺐ ﻣﺘﻤﺎﺛѧﻞ وﻏﻴѧﺮ ﻣﺘﻤﺎﺛѧﻞ ﻣѧﻦ 721
 وﻟﻬѧﺎ ﻓﺎﻋﻠﻴѧﺔ ﺗﺮﻳѧﺎزول, اﻳﻤﻴѧﺪازول, ﺑѧﺎﻳﺮازول, أوآѧﺰﻳﻢ, آﻴﺘѧﻮن, هﻴﺪروآѧﺴﻴﺒﻨﺰﻳﻞ-4, ﺁﻳﺰوﺑﺮوﺑѧﻞ, ﺑﻨﺰﻳѧﻞ:  ﻣﺜѧﻞﺘﻠﻔѧﺔﻣﺨ
 ﺑﻮاﺳﻄﺔ هѧﺬﻩ اﻟﻄﺮﻳﻘѧﺔ أﻋﻄѧﺖ ﻧﻤѧﺎذج واﻋѧﺪة ذات ﻗѧﺪرة ﺗﻢ اﻟﺤﺼﻮل ﻋﻠﻴﻬﺎ إن اﻟﻨﺘﺎﺋﺞ اﻟﺘﻲ  . آﻤﺎﺿﺪات ﻟﻔﻴﺮوس اﻻﻳﺪز 
ﻟﻠﻨﻤѧﻮذﺟﻴﻦ اﻟﻠѧﺬﻳﻦ  057.0  و 347.0 ﺗﺮﺑﻴﻌѧﻲ ﻗﻴﻤﺘѧﻪ رﺗﺒѧﺎط  ا وﺑﻤﻌﺎﻣѧﻞ . ﺑﻔﺎﻋﻠﻴﺔ ﻣﺮآﺒﺎت ﺗﺤﺖ اﻟﻔﺤﺺﻋﺎﻟﻴﺔ ﻋﻠﻰ اﻟﺘﻨﺒﺆ
  .ﺣﺼﻠﻨﺎ ﻋﻠﻴﻬﻤﺎ
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1.1 Computational chemistry 
   
Computational chemistry is a field that can be considered old and young. It is old 
because its foundation was laid with the development of quantum mechanics in the 
first quarter of the twentieth century. It is young because digital computers which are 
the  instrument of the computational chemists haven't developed until the last 40 years 
or so [1].  
Computational chemistry is the application of chemical, mathematical and 
computational skills to solve chemical problems. Generating information such as 
properties of molecules, investigations of materials that are too expensive or too 
difficult to find, and making predictions before running the actual experiments have 
become possible using computational chemistry. 
Schroedinger equation which is the basis of the most computational chemistry, 
scientists models the atoms and molecules with mathematics [2].  
HΨ = EΨ                                                                                       (1) 
E: is the energy of the system relative to one in which all atomic particles are 
separated to infinite distances , Ψ (PSI): is the wave function which defines the 
cartesian and spin coordinates of the atomic particles and H: is the Hamiltoninan 
operator which includes terms for both potential and kinetic energy. 
Schroedinger equation can be used to predict and calculate atoms energy as electrons 
move around. But it can be solved only for one electron atoms (hydrogen and helium). 
So if we need to extend using the method to larger atoms, we have to introduce 
approximations. 
Chemistry problems can be approached by two ways, computational quantum 
chemistry (CQC) and non-computational quantum chemistry (NCQC), CQC concerns 
with the numerical computation of molecular electronic structures while NCQC deals 
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with formulation of analytical expressions for the properties of molecules and their 
reactions. 
 
There are three different methods to make calculations: 
1- ab initio: a method where schroedinger equation is used to calculate molecular 
structures. 
2- Semi-empirical: a method uses approximations from experimental data input 
into mathematical models. 
3- Molecular mechanics: explaining and interpreting atoms and molecules 
behavior using classical physics. 
 
As a summary, computational chemistry calculations are based primarily on 
schroedinger equation which includes electron and charge distribution calculations, 
elementary reactions rate constants, details of the dynamics of molecular collisions, 
potential energy surfaces, and ground and excited states molecular geometry.  All of 
these calculations are useful for the determination of properties that are inaccessible 
experimentally and experimental data interpretation. 
 
Computational chemistry can serve many areas such as drug design, prediction of 
molecular structures, electron and charge distribution, and developing mathematical 
models to correlate structure with activity as shown in this study.  
  1.2 QSAR background and History  
Quantitative structure activity relationship (QSAR) is the quantitative correlation of 
structural properties of a compound with its chemical, physical, pharmaceutical, or 
biological effect.  Based on this assumption, many trials were made to correlate 
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various physicochemical properties of a set of molecules with their experimentally 
known biological activity, and so that summarizes QSAR goals in: 
1- Prediction of the activity of untested molecules, depending on models developed 
using a series of molecules of the same core.   
 
2- Constructing ideas about mechanism of action of a group of compounds leading to 
 a design of a new compounds of better activity and less toxicity. 
 
More than a century ago, QSAR related study was developed when Crum- Brown and 
Fraser expressed that a substance physiological action (Φ) was a function (f) of its 
chemical constitution(C). 
Φ=f(C)                                                                                                  (2) 
Later, in1893, the cytotoxicity of a set of simple organic molecules were correlated 
inversely with their water solubility by Richet. At the turn of the 20th century, Meyer 
and Overton showed that the narcotic action of a series of organic compounds is 
closely related to their oil water partition coefficient [3].  
In 1962 Hansch et al. published their QSAR study which correlates plant growth 
regulators with Hammett constants and hydrophobicity. Using octanol/water system a 
new hydrophobic scale was introduced, the relative hydrophobicity of a substituent 
(π): 
 
 π= log(Px/PH)                                                                                        (3)  
Px= partition coefficient of a derivative. 
PH= partition coefficient of a parent compound. 
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1.3 QSAR model development steps 
 Model development process is typically divided into three steps: data preparation, 
data analysis, and model validation [4].  
1.3.1 Data preparation 
Data preparation starts by selection of the data set to be used, this may simply be the 
extraction of data from a database or may need additional experimental studies.  
In our study we extracted the data from the literature [5], data preparation also was 
included in the calculation of molecular descriptors [6]. 
 
The list of compounds chosen has similar backbone structure but differ in   substituent 
groups. There are two steps to complete data preparation: geometry optimization and 
descriptors calculation. 
1.3.1.1 Geometry optimization. 
Geometry optimization or minimization is finding the coordinates that represents the 
potential energy minimum for the molecular structure in its 3D form. This is done 
using computer software such as hyperchem [7].  
To optimize molecular structures, hyperchem can use molecular mechanical methods 
or quantum (semiempirical or ab initio) mechanical methods. 
Although you must have parameters available before running a calculations in semi 
empirical method, but its preferred over ab initio because it is faster and can calculate 
values closer to the experimental values [8] . 
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1.3.1.2 Descriptors calculation 
Theoretical molecular descriptor is a value that describes the molecular structure 
numerically [2]. These descriptors can be simple such as molecular weight or 
complex such as geometrical descriptors. The models we aimed to build are a 
correlation between the molecular activity (dependent variable) and its molecular 
descriptors (independent variables). 
There are many software programs that can calculate theoretical molecular descriptors 
such as dragon software.  Dragon software can calculate more than a thousand of 
descriptors for one molecule in one step. Dragon descriptors are classified in 18 
groups such as topological, geometrical, quantum chemical, etc [9].  
 
1.3.2 Data analysis 
The first step in data analysis is to decide which techniques for statistical analysis and 
correlation to be used. If our correlation models to be built are linear then we use 
multilinear regression or non linear then we use artificial neural network [6]. 
 
QSAR techniques are applied upon compounds of a common pattern and variable 
functional groups with an experimentally determined activity, and then the molecular 
descriptors are defined to characterize the structural features of the series of 
compounds. These descriptors act as the independent variables in the correlation 
equation which relates them with the dependent variable (biological activity) [6]. 
In our study we performed multiple linear regression (MLR), principal component 
analysis (PCA), and artificial neural network (ANN) to build our linear and nonlinear 
models. 
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1.3.2.1 Simple linear regression 
Simple linear regression model contains only one independent variable, in our case 
the independent variable is a descriptor, so it is a simple relation between activity and 
only one descriptor. 
Each independent variable (descriptor) needs its separate model, and ignoring of the 
multiple descriptors interaction. 
1.3.2.2 Multiple linear regressions (MLR) 
MLR is multivariate statistical technique used to examine a linear relationship 
between the single dependent variable (activity) and two or more independent 
variables (molecular descriptors). MLR is based on least squares: the model is fit such 
that the sum-of-squares of differences of observed and predicted values is minimized. 
 The model equation is: 
Yi=bo+ b1Xi,1+ b2xi,2 +…….+ bk + Xi,k + Ei                                (4) 
      Xi..k  =  independent variables 
b1…k= regression coefficients 
bo = the intercept 
Y = dependent variable 
Ei = error term 
 
The relationship between the dependent variable and the independent variables is 
linear. The MLR model applies to linear relationships. If relationships are nonlinear, 
then we have to transform the data to make the relationships linear, or use an 
alternative statistical model (e.g., neural networks) [10]. 
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1.3.2.3 Principle component analysis (PCA) 
Principle Component Analysis is multivariate statistical method; it is useful tool for 
reducing the number of variables in a data set and for obtaining useful two 
dimensional views of a multi-dimensional data set. 
A Principal Component Analysis of the data set will determine the perpendicular axes 
(eigenvectors) which are defined by the dimensions of the data set. There will be the 
same number of axes as variables/dimensions. The longest axis is the first principle 
component (PC1). The next major axis is the second principle component (PC2). PC1 
and PC2 represent the most information contained in the independent variables. 
1.3.2.4 Artificial neural networks (ANN) 
A neural network is an attempt to simulate the brain. ANN revolves around the idea as 
biological neurons to construct more information and thus understand more in every 
round, so the work of the components of ANN are an attempt to recreate the 
computing potential of the brain. But it is important to know that no one has ever 
claimed that ANN is complicated as an actual brain. 
An input is presented to the neural network and target response set at the output. An 
error is the difference between the desired response and the system output. This error 
information is fed back to the system and adjusts the system parameters in a 
systematic fashion (the learning rule). The process is repeated until the performance is 
acceptable. 
 The neurons (hidden units) are non-linear transformation functions. Non linear 
models can be constructed when more than one of these neurons is used. ANN can 
model a wide set of functions, as in figure (1.1). The input is multiplied by the 
connection weight, while products are summed at each neuron where a nonlinear 
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transfer function is applied. The output of each neuron is then multiplied by the 
connection weight and summed and interpreted until having the minimum error [10].   
 
 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
Figure (1.1): Neural network flow diagram. 
 
1.3.3 Model validation 
    
Model validation is the final part of the model development process, the predictive 
power of the model is tested on an independent set of compounds, generally 
predictive power is the most important characteristics of the model, and model 
predictivity is the ability of the model to predict accurately the target activity of a 
compound that was not used for model development [4]. 
 
Most of validation processes implement the leave one out (LOO) and leave many out 
(LMO) cross-validation procedures.  The most common outcome parameters resulted 
from cross-validation procedures are cross-validated determination coefficient q2 
(R2cv) and root mean squares error (RMSE). 
 
q2 = 1- (∑ (Yobs - Ycalc)2 / ∑ ( Yobs - Ymean)2 )                       (5)  
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q2= R2=square determination coefficient  
Yobs = represents observed value 
Ycalc = represents calculated value 
Ymean = represents average of observed values 
       
RMSE = (1/ n ∑ ( Yi – Yx  )2)1/2                                               (6) 
Yi: response for the ith observation  
Yx: response for the predicted 
 
High R2cv and low RMSE values is a result of good and more predictive model  and 
that lead to better description of the observed data [11].   
1.4 QSAR advantages and disadvantages 
QSAR advantages are: 
 
• QSAR provides quantitative information that relates properties of a 
compound to its activity, and this will provide an understanding of the 
effect of the structure on the activity. QSAR is an effective mean of 
modifying drug molecules by insilico design and enhancement.  
• QSAR results can be used to understand interactions between functional 
groups in the molecules of greatest activity with targets functional 
groups. 
• Finally and the most important advantage of QSAR is that  we can use 
QSAR resultant models outside the range of the data set; the model can 
be used to design new drugs depending on the most effective descriptors. 
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While QSAR disadvantages are: 
• Any cross-correlated physicochemical parameters will give a deviation in the 
result. Therefore, only variables that have little co-variance should be used in a 
QSAR analysis. 
• Many QSAR models can't confidently predict the most likely compounds of 
best activity, because the data collected may not reflect the complete property 
space. 
•  Considerable experimental error may result if false correlations may arise 
through too heavy reliance being placed on biological data. 
 
1.5 Software in QSAR 
    A huge number of computer programs to serve QSAR produced in the last 50 
years, these programs help in the progression of QSAR and make it easy to achieve all 
QSAR goals. 
The five software's used in our research are: 
HyperChem (version 8.0 HyperCub, Inc.), Dragon (version 3, Milano Chemometrics 
and QSAR research group, http://www.dist.unimib.it/chm/Dragon.htm), SPSS 
(version 11.50, SPSS Inc.), Matlab (version 7.0, Math works Inc, 
http://www.mathworks.com) and multiple Back Propagation version 2.2.1. 
1.5.1 Hyperchem 
 Hyperchem software is a sophisticated molecular modeling environment that is 
flexible, easy to use, and high quality program. Hyperchem integrates 3D 
visualization and animation with quantum chemical calculations, molecular 
mechanics, and dynamics. 
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Hyperchem can be used to: building molecular structures, structure optimization, 
calculating some QSAR descriptors, computing some structural properties, studying 
dynamic behavior, etc. 
In this research we used the hyperchem software to build the structure, optimizing the 
structure, and to calculate some structural properties and molecular descriptors. 
Before calculation of any property of the molecule, the structure must be optimized 
(minimized). 
 
The different tool menu is shown in figure (1.2) where we can use any tool to draw, 
display, optimize, calculate, and then we can use the model builder to transform (2D) 
structures to (3D) structures. 
 
 
Figure (1.2): Hyperchem main menu. 
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1.5.2 Dragon software 
 
Dragon software is designed for the calculation of theoretical molecular descriptors, it 
is  developed by Milano chemometrics  and QSAR research group to calculate 
molecular descriptors for molecules containing the following atoms: C, H, O, N, S, P, 
F, Cl, Br, I, B, Si, Ni, Fe, Co, Al, Cu, Zn, Sn, Gd. 
 Different descriptors can be calculated by Dragon software, and this huge number of 
descriptors is divided into 18 groups such as: topological and geometrical descriptors 
as shown in figure (1.3). 
Descriptors calculated by Dragon represent an input to the QSAR analysis programs, 
these descriptors are the independent variables in the models that we aim to build. 
 
 
           
          Figure (1.3): Dragon main menu 
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1.5.3 SPSS software 
 
SPSS (Statistical Package for the Social Sciences) was released in 1968 after being 
developed by Norman H. Nie and C. Hadlai Hull. SPSS is the most widely used 
program for statistical analysis, it uses two main windows: data editor and output 
viewer.  
 1.5.3.1 Data Editor 
This is a spreadsheet-like window which contains the data be analyzed. The data 
editor has two views:  
Data View which contains the data and is the view we see when we open the data 
editor, figure 1.4.  When we click the tab at the bottom of the window brings up the  
Variable View which does not contain data, but displays information about the 
dataset that is stored, figure (1.5). We can control how SPSS displays data from this 
window. 
Each data editor contains one dataset. Multiple data editors can be opened at one time, 
in which each one contains a separate dataset. Datasets that are currently open are 
called working datasets. All data manipulations, statistical functions, and other SPSS 
procedures operate on these datasets. 
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Figure (1.4): Data view window 
 
 
Figure (1.5): Variable view window  
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1.5.3.2 Output Viewer     
This is where the results of any analysis appear. From the viewer, we can format the 
output in a wide range of ways, and export results in a variety of formats, e.g. text, 
SPSS, MSWord, MSExcel, etc. 
In this study we will use SPSS software to perform MLR analysis. 
1.5.4 MATLAB software 
A high-level language and interactive environment program that enables us to 
perform computationally intensive tasks faster than with traditional programming 
languages such as C, C++, and Fortran. 
Wide range of applications can be performed by matlab, including image processing, 
test and measurements, control design, and computational biology. 
The main use of matlab in our study is to do cross validation (LOO and LMO) and to 
perform principal component analysis before starting ANN. The use of matlab 
depends upon the script used and the input files. 
 
1.5.5 MBP software 
Multiple Back-Propagation is a software application for training neural networks with 
the back propagation  and multiple back propagation algorithms. 
Before starting MBP we should save the input dataset files in a way that MBP can 
understand them, and the data should be divided into training and test sets, dividing 
the data depending on the results of the principal component analysis. Then the 
network parameters and activation functions of the neurons must be configured. 
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The input of the MBP is the output models of SPSS chosen depending upon the 
models statistical parameters such as regression coefficient (R) and cross validation 
parameters.  
1.6 AIDS and HIV protease inhibitors 
1.6.1 AIDS 
Acquired Immune Deficiency Syndrome (AIDS) is an immune system disease 
characterized by reduction of the effectiveness of the immune system leaving the 
individual susceptible to opportunistic infections and tumors. AIDS is transmitted due 
to direct contact of blood or body fluids with those of a body containing AIDS [5].  
 
The causative agent of AIDS is the Human Immunodeficiency Virus (HIV), a 
member of the family of retroviruses, HIV primarily infects vital organs of human 
immune system such as CD4+T cells (subpopulation of T lymphocytes), 
macrophages, and dendritic cells, and destroys CD4+ T cells [5].  
 
T lymphocytes play a major role in defense against intracellular pathogens such as 
viruses, protozoa and intracellular bacteria, and are also involved in immunity to 
extracellular pathogens by providing "help" for the antibody response. 
 
The role that the CD4+T cells plays in the elimination of intracellular micro-
organisms such as Mycobacteria (e.g. in tuberculosis and leprosy) and Candida. 
CD4+Tcells play a central role in regulating the cell mediated immune response to 
infection. These cells are often known as "helper" T cells, as they act on other cells of 
the immune system to promote various aspects of the immune response, including 
 18
immunoglobulin isotype switching and affinity maturation of the antibody response, 
macrophage activation, and enhanced activity of natural killer (NK) cells and 
cytotoxic T cells (CTL). 
 Although there is no cure for acquired immunodeficiency syndrome (AIDS), 
medications have been highly effective in fighting HIV and its complications. Some 
of the drugs approved by the FDA for treating HIV and AIDS are listed below [12]. 
• Protease inhibitors.  
Protease inhibitors interrupt a later stage of viral replication. This class of drugs 
includes saquinavir, indinavir, ritonavir, nelfinavir, and amprenavir. 
• Nucleoside analog reverse transcriptase inhibitors (NRTIs). 
 These drugs interfere with the activity of reverse transcriptase.  
AZT (zidovudine), the first drug approved for treating HIV infection, is an NRTI. 
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs).  
  Work by hindering the action of reverse transcriptase. This class of drugs 
includes delavirdine, nevirapine, and efavirenz. 
• Fusion inhibitors. 
  Fusion inhibitors prevent HIV from entering human immune cells. The only 
fusion inhibitor approved to date is  isenfuvirtide. 
• Integrase inhibitors.  
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Work by disabling integrase, a protein that HIV uses to insert its genetic material 
into CD4 cells. This group of drugs includes Raltegravir (Isentress). 
 
• Highly Active Antiretroviral Therapy (HAART) 
           Also called anti-HIV "cocktail" — is a combination of three or more drugs.  
The treatment is highly effective in slowing the rate of HIV virus replication, which 
may slow the spread of HIV in the body. 
 
1.6.2 Protease Inhibitors  (PIs) 
Human Immunodeficiency Virus is a virus that goes through many steps during its' 
life cycle. When HIV infects a human cell, HIV uses proteins and chemicals inside 
that cell to make more copies of itself. Protease is a chemical that HIV needs in order 
to make new viruses [13]. 
Protease Inhibitors (PIs) are a group of compounds used to treat or prevent infection 
by viruses, including HIV. The biggest news and the greatest benefits to people with 
HIV came when protease inhibitors (PIs) were discovered and made into anti-HIV 
treatments [13].      
 
When people started taking PIs in combination with other drugs, the number of people 
who became ill from opportunistic infections, or died from AIDS, dropped by about 
70%. 
 
Saquinavir was the first protease inhibitor approved by the FDA (December 6, 
1995).After that  many drugs were approved by the FDA, e.g  Darunavir and 
Tipranavir. These compounds have a core structure that is slightly similar to the 
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structure core of our research compounds, as shown in the figures (1.6), (1.7), and 
(1.8). 
 
Figure (1.6): Saquinavir structure 
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Figure (1.7): Structural core of tricyclic urea 
 
N N
N
N
OHHO
R R
 
 
Figure (1.8): Structural core of nonpeptide cyanoguanidine derivatives.     
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1.6.3 HIV 1 Protease 
The HIV protease is a C2-symmetric homodimeric enzyme consisting of two 99 
amino acid monomers. Each monomer contributes an aspartic acid residue that is 
essential for catalysis, Asp-25 and Asp-25´. The HIV protease has the sequence Asp-
Thr-Gly, which is conserved among other mammalian aspartic protease enzymes. An 
extended beta-sheet region on the monomers, known as the flap, constitutes in part the 
substrate binding site with the two aspartyl residues lying on the bottom of a 
hydrophobic cavity. Each flexible flap contains three characteristic regions: side 
chains that extend outward (Met46, Phe53), hydrophobic chains extending inward 
(Ile47, Ile54), and a glycine rich region (Gly48, 49, 51, 52). Ile50 remains at the tip of 
the turn and when the enzyme is unliganded a water molecule makes hydrogen bonds 
to the backbone of Ile50 on each monomer. 
HIV proteases catalyze the hydrolysis of peptide bonds with high sequence selectivity 
and catalytic proficiency. The mechanism of the HIV protease shares many features 
with the rest of the aspartic protease family although the full detailed mechanism of 
this enzyme is not fully understood [14]. 
 
Aspartyl Protease (PR) that is responsible for gag and gag-pol polyproprotein 
cleavage. This process is essential for the maturation of the virus as shown in figure 
(1.9). Inhibition of this enzyme produces non-infectious virus [15].  
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Figure: (1.9) HIV life cycle. 
 
1.6.4 Mechanism of action 
Protease Inhibitors (PIs) block the protease enzyme by binding its active site as shown 
in figure (1.10). When protease is blocked, HIV makes copies of itself that can't infect 
new cells. Studies have shown that protease inhibitors can reduce the amount of virus 
in the blood and increase CD4 cell counts. In some cases these drugs have improved 
CD4 cell counts, even when they were very low or zero [14]. 
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Figure (1.10): A simplified image of a protease inhibitor binding to the active site of 
the HIV-1 protease. 
 
The above figure shows that the central core with the hydroxyl group forming 
hydrogen bonds with Asp-25 and Asp-25´. Hydrogen bonds also connect carbonyl 
groups on the inhibitor to the water molecule linked to Ile50 and Ile50´. 
 
Many X-ray crystal structures of HIV-1 PR interacting with cyclic urea derivatives 
are available in the Protein Data Bank (PDB). 1QBS, (http://www.rcsb.org/pdb/, 
Brookhaven National Laboratory, Protein Data Bank, file 1QBS), is one of them. 
Where the cyclic urea inhibitor, DMP323, (compound 115 of our data), was used as 
template X-ray crystal structure for HIV-1 PR inhibitors modeling. The cyclic 
cyanoguanidine and cyclic urea derivative inhibitor structures were varied by 
replacing specific substituents in the reference DMP323 structure, for which the anti-
viral activity has been evaluated [5]. 
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Not surprising that protease enzyme represents the most attractive target site for 
development of therapeutic agents for treatment of AIDS, the most agents target this 
site are cyclic urea and non-peptide cyclic cyanoguanidine derivatives [6]. 
Cyclic urea compounds and cyanoguanidine derivatives which used in this study work 
against AIDS by this mechanism, and so they work against wild type and mutants 
HIV1 PR.  
1.7 Objective  
The objective of this study is to develop ANN-QSAR models for the Inhibition 
activity of symmetrical and unsymmetrical cyclic urea and cyclic cyanoguanidine 
derivatives of wild type and mutant HIV-1 protease by calculating all Dragon  
descriptors and use higher statistical qualities other than MLR. 
 
These developed models can be used later to predict the activity of other anti HIV1 
PR compounds having the same structural core, and to design new drugs with better 
activity.   
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QSAR is an indirect method to calculate the molecular activity; we must know the 
correct molecule receptor interaction in vivo to calculate the activity accurately, this is 
achieved by correct QSAR model building steps.  
QSAR model development methodology consists of four steps: 
1. Data preparation. 
2. Descriptors calculation. 
3. Statistical analysis. 
4. Model validation. 
 2.1 Data preparation. 
2.1.1 The compounds name and log1/ki. 
127 compounds and their observed activity expressed as log1/Ki were taken from 
reference [5]. The observed activity are examined invitro using infected cultures. The 
inhibition constant, Ki, is an indication of how potent an inhibitor is; it is the 
concentration required to produce half maximum inhibition. Molecular structures and 
activities of these compounds as HIV-1 PR inhibitors are summarized in table (2.1). 
  
Table (2.1): Molecular structures and observed activities of the 127 HIV-1 PR cyclic 
urea and non peptide cyanoguanidine derivative inhibitors expressed as log 1/Ki. (R) 
and (X) in all structures represents the substituent. 
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O
RR
OHOH   
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Compound 
number 
Index*  Substituent (R)  (log 1/ Ki) 
observed 
1 Mol 1  Benzyl 8.47 
2 Mol 8  methyl 5.30 
3 Mol 16  4-isopropylbenzyl 8.96 
4 Mol 25  4-(methylthio) benzyl 8.47 
5 Mol 27  2-(methylthio) ethyl 5.96 
6 Mol 28  3-indolylmethyl 6.24 
7 Mol 29  cyclohexylmethyl 7.56 
8 Mol 30  phenethyl 6.50 
9 Mol 31  2-naphthylmethyl 8.01 
10 Mol 32  3-furanylmethyl 8.08 
11 Mol 33  3-(methylthio) benzyl 8.61 
12 Mol 34  4(methylsulfonyl) benzyl 8.61 
13 Mol 35  2-metoxybenzyl 7.23 
14 Mol 36  2-hydroxybenzyl 7.46 
15 Mol 37  3- metoxybenzyl 8.33 
16 Mol 38  4- metoxybenzyl 8.07 
17 Mol 39  4- hydroxybenzyl 8.96 
18 Mol 40  3-aminobenzyl 8.56 
19 Mol 41  3-(dimethyl aminobenzyl) 8.37 
20 Mol 42  4- aminobenzyl 8.08 
21 Mol 44  4(dimethylamino) benzyl 7.34 
22 Mol 45  4-pyridylmethyl 7.66 
23 Mol 46  3-(2,5dimethylpyrolyl) 
benzyl 
6.80 
24 Mol 47  3,4(methylenedioxy)benzyl 8.89 
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O
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N N
O
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OHOH
OHOH
 
 
Compound 
number 
Index*  Substituent (R)  (log 1/ Ki) 
observed 
36 Mol 61  benzyl 9.57 
37 Mol 62  2-(methylthio) 
ethyl 
5.41 
38 Mol 63  cyclohexylmethyl 7.50 
39 Mol 64  4-fluorobenzyl 9.36 
40 Mol 65  3- metoxybenzyl 9.96 
41 Mol 66  3,4-
difluorobenzyl 
9.33 
42 Mol 67  4-pyridylmethyl 8.32 
43 Mol 68  4- metoxybenzyl 9.62 
44 Mol 69  isobutyl 7.43 
 
Compound 
number 
Index*  Substituent (R)  (log 1/ Ki ) 
observed 
25 Mol 2  benzyl 8.73 
26 Mol 51  isobutyl 7.07 
27 Mol 52  isopropyl 6.61 
28 Mol 53  2-(methylthio)ethyl 5.61 
29 Mol 54  4-fluorobenzyl 8.24 
30 Mol 55  2-metoxybenzyl 7.19 
31 Mol 56  3- metoxybenzyl 9.07 
32 Mol 57  3- hydroxybenzyl 7.89 
33 Mol 58  4- metoxybenzyl 8.54 
34 Mol 59  2-naphthylmethyl 8.37 
35 Mol 60  3,5-dimetoxy-
benzyl 
8.57 
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Compound 
number 
Index*  Substituent (R)  (log 1/ Ki) 
observed 
45 9b  alyl 8.29 
46 9c  n-propyl 8.10 
47 9d  n-butyl 8.86 
48 9e  3,3-dimethylallyl 8.80 
49 9f  3-methylbutyl 7.93 
50 9g  cyclopropylmethyl 8.68 
51 9h  cyclobutylmethyl 8.89 
52 9I  cyclopentylmethyl 8.37 
53 9j  cyclohexylmethyl 7.44 
54 9k  benzyl  8.53 
55 9l  3-nitrobenzyl  8.56 
56 9m  4-nitrobenzyl 7.50 
57 9n  3-aminobenzyl  9.56 
58 9o  4- aminobenzyl 8.96 
59 9p  3-cyanobenzyl  8.53 
60 9q  4-cyanobenzyl  7.29 
61 9r  3-hydroxybenzyl 9.93 
62 9s  4-hydroxybenzyl  9.93 
63 9t  3-(benzyloxy) 
benzyl 
6.47 
64 9u  4-(benzyloxy) 
benzyl 
6.27 
65 9v  3(hydroxymethyl) 
benzyl 
9.86 
66 9w  4(hydroxymethyl) 
benzyl 
9.47 
67 9x   2naphthylmethyl 9.51 
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Compound 
number 
Index*  Substituent (R)  (log 1/ Ki) 
observed 
68 8b  alyl 7.44 
69 8c  n-propyl 7.86 
70 8d  n-butyl 8.57 
71 8e  3,3-dimethylallyl 7.53 
72 8f  3-methylbutyl 8.43 
73 8g  cyclopropylmethyl  7.66 
74 8h  cyclobutylmethyl  8.70 
75 8I  cyclopentylmethyl  8.83 
76 8j  cyclohexylmethyl  8.25 
77 8k  benzyl  7.70 
78 8l  3-nitrobenzyl  7.05 
79 8m  4-nitrobenzyl  7.18 
80 8n  3-aminobenzyl  8.14 
81 8o  4-aminobenzyl  7.61 
82 8p  3-cyanobenzyl  7.58 
83 8q  4-cyanobenzyl  6.90 
84 8r  3-hydroxybenzyl 9.15 
85 8s  4- hydroxybenzyl  8.59 
86 8v  3-(hydroxymethyl) 
benzyl 
8.77 
87 8w  4-(hydroxymethyl) 
benzyl 
7.96 
88 8x  2naphthylmethyl  7.66 
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Compound 
number 
Index*  Substituent 
(R)  
Substituent 
(X) 
(log 1/ Ki) 
observed 
89 5a  H O 9.36 
90 5b  Me O 10.23 
91 5c  Et O 9.68 
92 5d  nPr O  8.86 
93 5e  CF3 O  10.44 
94 5f  tBu O  8.45 
95 6a  H N(OH)  11.01 
96 6b  Me N(OH)  10.75 
97 6c  Et N(OH)  10.51 
98 6d  nPr N(OH)  10.51 
99 6e  CF3 N(OH)  8.41 
 
N N
OHOH
O
PhPh
RR
 
 
Compound 
number 
Index*  Substituent (R)  (log 1/ Ki) 
observed 
100 10a 
 
10.57 
101 10b 
 
9.21 
102 10c  
 
9.80 
103 10d  
 
9.73 
104 10e  
 
9.77 
105 10f  
 
10.29 
106 10g  
 
8.19 
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Compound 
number 
Index* Substituent (R)  (log 1/ Ki) 
observed 
107 12a  H 9.59 
108 12b  
 
9.86 
109 12c   9.80 
110 12d  
 
10.46 
111 12e  
 
9.77 
112 12f  
 
10.68 
113 12g  
 
10.29 
          
 
N N
OHOH
O
RR
 
 
Compound 
number 
Index*  Substituent (R)  (log 1/ Ki) 
observed 
114 XK234  
 
8.24 
115 DMP323  
 
9.08 
116 DMP450  
 
9.39 
117 XNO63  
 
10.10 
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118 XP521  
 
10.53 
119 XR835  
 
10.40 
120 XZ442  
 
9.75 
121 SB561  
 
10.05 
122 SB570  
 
10.10 
123 SB571  
 
10.05 
124 SD146  
 
10.01 
125 XV638  
 
9.96 
126 XV643  
 
9.86 
127 XV652  
 
10.31 
*: According to reference [5]. 
2.1.2 Structures drawing and optimization 
The structures of the compounds are taken from reference [5] and then drawn by 
hyperchem software. The resultant structures are 2D, after that we convert them to 
3D. Then AM1, semi-empirical quantum mechanical method was used for the 
geometry optimization. To be sure that we reached global minima, geometry 
optimization was run multiple times with different starting points for each molecule.   
There are many steps to perform geometry optimization: 
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1. Draw the structure using drawing tools. 
2. Click on start log in the file menu to write the file name, and choose a directory to 
save it. 
3. From the setup menu choose semi-empirical method of calculation and then click 
on AM1in the semi-empirical window as shown in figure (2.1). 
 
   
 
Figure (2.1): semi-empirical method window.  
4. Click on the options button of the semi-empirical window and select geometry 
optimization parameters, choose total charge= 0, spin multiplicity= 1, spin pairing = 
RHF, convergence limit=0.1, and accelerate convergence= yes as shown in figure 
(2.2). 
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      Figure (2.2): Semi-empirical options window. 
 
5. Click OK to close the semi-empirical options dialog box , and then click OK to 
close the semi-empirical  method dialog box.   
 
6. Choose geometry optimization from compute menu, this opens semi-empirical 
optimization dialog box as shown in figure (2.3). 
 
  
  
Figure (2.3): Semi-empirical optimization window  
  
7. Select Polak-Ribiere as algorithm method, choose 0.1 for RMS gradient condition, 
and the default values for the other variables, then click OK to initiate the 
optimization and close the dialog box. 
8. When the program finish optimization, select stop log from the file menu to save 
the calculation output as log file. 
2.2 Descriptors calculation 
Theoretical molecular descriptor is the bridge that connects the optimized structure 
with the biological activity; we have to calculate molecular descriptors for our 
optimized structures to continue our model building steps. 
Structure can't be linked directly with the activity, but the descriptor which is a 
mathematical value can be used to derive a relationship with the activity and also 
build a model which will be used to predict the activity of other molecules in the same 
family of our dataset.  
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Descriptors can be simple to understand and interpret such as number of carbon atoms 
or complex. In our study we calculate all dragon descriptors and some other 
descriptors calculated by hyperchem directly and indirectly. Table (2.2) describes 
briefly some of the descriptors used in our study. 
Table (2.2):  Brief description of some descriptors used in this study. 
  
Molecular DescriptorsDescriptors Type
Molecular weight (MW),  number of atoms (nAT),  number of non 
H-atoms (nSK), number of bonds (nBT), number of multiple 
bonds (nBM), number of rings (nCIC), number of circuits (nCIR), 
number of H-bond donor (nHDon), number of H-bond acceptor 
(nHAcc). 
Constitutional 
Information index molecular size (ISIZ), connectivity indices(X), 
average connectivity index (XA), kier symmetry index (S0K), 
total walk count (TWC), Zagreb index (Z), Schultz molecular 
topological index, Balaban j index (J), Wiener w index (W) 
Topological 
indices
Highest occupied molecular orbital energy(EHOMO), Lowest 
unoccupied molecular orbital energy (ELUMO), Most positive 
charges(MPC), Least negative charges (LNC), Most negative 
charges(MNC),  Sum of positive charges(SPC), Sum of negative 
charges (SNC),  Sum of squares of positive charges (SSPC),  Sum 
of squares of negative charges(SSNC),Sum of squares of charges 
(SSC), Sum of absolute of charges (SAC) ,molecular Dipole 
moment (DM) , Electronegativity (χ=-0.5(EHOMO-ELUMO)) 
.Hardness(η=0.5(EHOMO+ELUMO)).Softness(S=1\η).Electrophilicity 
Quantum 
Chemical 
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(ω=χ2/2η). Heat of formation (Hf ). 
Octanol-water partition coefficient, (LogP), hydration energy (HE) 
polarizability (Pol), refractivity (Ref), volume (V), surface area 
(SA).   
Chemical 
descriptors
 
2.2.1 Description of some descriptors 
This section provides information about some descriptor classes and an example of 
each class. 
2.2.1.1 Constitutional descriptors 
Constitutional descriptors are 0D descriptors reflect the molecular composition, they 
are independent from conformation and molecular connectivity. These descriptors are 
calculated by dragon software. Examples of these descriptors are shown in table (2.2). 
2.2.1.2 Topological indices  
This group of descriptors is 2D. They are directly and simply calculated by Dragon 
software.  
An example of these descriptors: Kier symmetry index used to encode the shape 
contribution due to symmetry. 
 
2.2.1.3 Descriptors calculated by hyperchem  
We can calculate HOMO (highest occupied molecular orbital energy) , LUMO 
(lowest unoccupied molecular orbital energy). Also we can extract dipole descriptors 
in the X, Y, Z direction as well as total dipole descriptor from the log file that result 
from the Hyperchem. Depending on the HOMO and LUMO values we can indirectly 
calculate electrophylicity, electronegativity, hardness, and softness descriptors. 
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Other descriptors such as surface area approximate, surface area grid. Volume, mass, 
polarizability, hydration energy, octanol-water partition coefficient (logP), and 
refractivity are calculated by performing these steps: 
 
1. Open the hyperchem file that contains the optimized 3D structure. 
2. From compute menu choose QSAR properties, this will open QSAR properties 
dialog box. 
3. Click on the property we want to calculate, and then click on the compute button of 
the QSAR properties dialog box as shown in figure (2.4). 
4. Repeat steps 2 and 3 for all QSAR properties in the dialog box. 
  
Figure (2.4): QSAR properties window.  
2.2.1.4 Descriptors calculated by dragon 
Other groups of descriptors such as Geometrical and Getaway and others are 
calculated by dragon software using these steps: 
1. In dragon software, choose compounds we want to calculate their descriptors.  
2. Click (stop calculation in error) button. 
3. Click descriptor selection icon and then choose group/groups of descriptors we 
want to calculate. 
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4. Click RUN icon to start calculation, and press save descriptors when the 
calculations end and name the output file.  
In our study we calculated each group of dragon descriptors of the optimized 
compounds; each descriptors group is calculated alone to give separate dragon output 
file which will be the input file for next statistical analysis step. 
2.3 Statistical Analysis 
2.3.1 Multiple Linear Regression (MLR).  
MLR is the way to find the best linear relation between the dependent variable 
(biological activity) and the independent variables (theoretical molecular descriptors). 
MLR can choose the best subgroup of descriptors that can provide the best prediction 
for each compound in the training set. 
In our study, SPSS was used to perform MLR analysis, the input files used in SPSS 
are the excel files contain descriptors calculated by hyperchem and dragon with the 
dependent variable added to each input file. 
To perform MLR analysis using SPSS software, use the following steps:  
1. Open the file containing the dependent variable and independent variables using 
SPSS, then go to analyze menu and choose regression and select linear as in figure 
(2.5). 
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Figure (2.5): SPSS Data Editor Menu 
2. Set log1/Ki as the dependent variable and set the descriptors of the input file as 
independent variables in the linear regression dialog box, and then press on the 
options button of the same dialog box as shown in figure (2.6). 
 
 
Figure (2.6): Linear regression box.  
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3. Select use F value and set F Entry and F Removal values and leave other 
parameters without any change in the linear regression option dialog box. 
4. Choose the method to be stepwise, click save to store results back to the input 
sheet, choose the predicted values to be unstandarized and then click continue. 
 5.  Click plots to generate plots of residuals, click statistics to generate additional 
statistics for variables, then click continue, and finally click OK in the linear 
regression dialog box. 
 Unfortunately, MLR some times does not produce good models, because the relation 
between the structure and the activity may be more complicated and nonlinear. To 
have more predicted models, we performed additional statistical analysis [10]. 
 
2.3.2 Artificial Neural Network (ANN) 
Principal components- Artificial neural network is the solution when the linear 
methods do not produce good predicting models. In our study we will use multiple 
back Propagation software to perform ANN.   
The steps of this method are: 
1. Choose some of the best  MLR models depending on their regression coefficient 
(R) and their cross validation parameters, and then prepare an excel files containing  
only the descriptors suggested by MLR models and the activity (log1/Ki), the activity 
should be the last column of the file. 
2. Data should be divided into training and test sets, test set should be 20% of the all 
data. PCA script was used to divide the data using  MATLAB software, the test set of 
compounds must represent all the data distribution area. 
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3. The multiple back propagation software will use the training set to train the 
network and the test set to optimize the network parameters and so minimize the 
error.   
4. After specifying the training and test set to MBP, we should specify the neural 
network topology by clicking on topology icon as shown in figure (2.7). Before 
starting network training we should randomize the weights in order to preview the 
current network output versus the desired one. 
 
 
Figure (2.7): ANN topology 
5. Define the activation function of the neurons, and also define the activation 
function of the output layer by clicking on the layer we want to define its activation 
function and then specify it. 
6.  By clicking the configuration button we will have access to more configurations, 
the default configuration works well for most cases but we still have the option to 
modify the learning configuration so that it fits with our requirement as shown in 
figure (2.8) 
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Figure (2.8): Network learning configuration default parameters. 
7. After defining our learning configuration parameters, we click the start button to 
start the network training. The number of hidden nodes must be the same for all 
models and all optimization cases. Depending upon cross validation parameters we 
will choose the best model.  
8. After choosing the best model, we have to optimize the number of hidden nodes for 
this model, so we use a range of hidden nodes from 2 to 20, and then run the network 
for each number. Finally choose the best number of hidden nodes depending on cross 
validation results of the model.  
2.4 Cross Validation 
Cross validation is the evaluation of the ability of the QSAR model to predict the 
property of the molecule, which is not in the original QSAR data set [11].  
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R2 (Pearson coefficient) is a statistical parameter that will give some information 
about the goodness of fit of a model. In regression, the R2 coefficient of determination 
is a statistical measure of how well the regression line approximates the real data 
points. An R2 of 1.0 indicates that the regression line perfectly fits the data. R2 is only 
a descriptive measure and it does not measure the quality of the regression model. 
Accordingly, focusing solely on maximizing R2 is not a good idea. Unfortunately, a 
high R2 (coefficient of determination) value does not guarantee that the model fits the 
data well. 
2.4.1 Cross Validation in MATLAB 
2.4.1.1 Leave One Out Cross Validation 
 
Leave-one-out cross-validation involves using a single observation from the original 
data as the validation data, and the remaining observations as the training data. This is 
repeated such that each observation in the sample is used once as the validation data. 
This type of cross-validation is usually expensive from a computational point of view 
because of the large number of times the training process is repeated [16]. 
This type of cross validation is done for both MLR and ANN models according to the 
following steps: 
1- Copy the observed and predicted activity columns from the SPSS data editor or the 
ANN output file and paste them in an excel file and save it. The observed activity 
should be the first column and then comes the predicted activities. 
 2- Copy excel file to Matlab working directory   (C:\MATLAB701\work) or any 
directory you are working in. In the same directory, there should be a file (script) with 
the name (cross_val_param_loop.m). 
 45
 
3- Open the script file, then you will have a message on Matlab window says “what is 
the file name”, enter the excel file name with or without the (.xls) extension. Then you 
will have a message says “model number”, where the next line contains number that 
is the model number.  
4- Matlab script will ask you for the number of descriptors for each individual model. 
Towards the end, cross validation results for all models will be saved in a file called 
“CV_LOO.dat” on the directory (C:\MATLAB701\work) or the directory you are 
working in. 
2.4.1.2 Leave Many Out Cross Validation 
In leave many out cross validation, the original sample is randomly partitioned into X 
subsamples. Of the X subsamples, a single subsample is considered as the validation 
data for testing the model, and the remaining X − 1 subsamples are used as training 
data. The cross-validation process is then repeated X times, using each of the X 
subsamples once as the validation data [16]. 
This type of cross validation is done just for MLR models according to the following 
steps: 
1- Prepare an excel file that contains the activity (first column) and the descriptors 
entered in the regression model of interest.  
2- Then run Matlab script “lgocv.m”. This script performs leave-group-out cross 
validation where 20% of the data are classified as test set so that each compound is 
entered only once in the test set.  
3- Enter excel filename and number of compounds to be used in the training set when 
you are asked for these information and press enter. 
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4-The output file: “CV_LGO.dat”, appears in the same directory in addition to 
printing cross validation parameters to screen.  
2.4.1.3 Chance Correlation 
In this test, we randomize the activity column of the optimal models by MATLAB 
software using special script and then the randomized model is checked using the 
same configuration parameters of the MBP. 
Then, we compare the cross validation results of the randomized models with the 
original models. If they are the same, this means that we our results are produced by 
chance.  
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 In continuation of recent QSAR studies [10] and [17-20] done using similar methods 
including nonpeptide HIV-1PR inhibitors [21] we developed an ANN-QSAR model 
that describes the anti-HIV activity of a series of compounds using large number of 
different descriptors. SPSS software and MBP software were used to build the linear 
and non linear models respectively. 
The structure of 127 compounds and their observed activity expressed as log 1/Ki 
were taken from reference [5] as shown in table (2.1). The chemical structure of each 
molecule was built by Hyperchem software. And then the structures were optimized 
by AM1 semi-imperical method. We calculated 18 different groups of descriptors 
using Dragon software. Two groups: Empirical and Properties desciptors are constant 
or near constant descriptors for all 127 compounds. Dragon software discard constant 
or near constant descriptors because they are correlated with each other and with 
activity at the same time. This will cause collinearity. Other groups are: constitutional, 
molecular walk counts, galves topological charge indices, charge descriptors, randic 
molecular profiles, RDF descriptors, WHIM descriptors, functional groups, 
topological descriptors, BUCT descriptors, 2D descriptors, aromaticity indices, 
geometrical descriptors, 3D-MoRSE descriptors, GETAWAY descriptors, and atom-
centered fragments. Other descriptors were calculated using Hyperchem software 
such as HOMO, LUMO, and polarizability.  
We have 16 dragon groups and we calculated group 17 of descriptors by hyperchem 
software directly and indirectly. MLR were performed on the 17 groups of descriptors 
individually rather than dealing with them as one group according to the work done 
recently by Deeb [22] where log1/Ki is the dependent variable and each group of 
descriptors are independent variables using SPSS software. Stepwise method is used 
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to develop multilinear equation by correlating dependent variable (activity) and the 
best independent variables. The MLR results are summarized in table (3.1). 
Table (3.1): Results of applying MLR on the 17 groups.  
       
 
No 
Group name R R2 R2adj. Standard 
Error of 
estimation
. 
 Selected descriptors. 
1 Constitutional 0.68 0.464 0.386 0.972 nDB, nS, nTB, nR04, nR05, nBnz, 
RBF, RBN, nN, nSK, Ss, Ms, Mv, 
nBM, nF, nCIC  
2 3D morse 0.82 0.672 0.618 0.767 Mor13v, Mor10m, Mor16v, 
Mor22m, Mor14u, Mor06m, 
Mor31m, Mor26m, Mor16m, 
Mor06v, Mor15m, Mor02u, 
Mor04u, Mor27u, Mor20u, 
Mor02v,       Mor19m,       Mor19u 
3 2D 
descriptors 
0.88 0.778 0.737 0.637 GATS2m, MATS6e, MATS8m, 
ATS5e, MATS4m, MATS7e, 
GATS8p, GATS1e, GATS4p, 
ATS7e, MATS6p, GATS6p,  
GATS7p, MATS4e, GATS4e, 
GATS8m, ATS8v, ATS1p, 
MATS8v,      MATS5e. 
4 Randic 0.45 0.204 0.191 1.116 DP04, SHP2 
5 Molecular 0.5 0.245 0.220 1.095 MWC05, MWC10, SRW03, 
MW09 
6 Aromatic 0.45 0.2 0.18 1.123 HOMT, ARON, HOMA 
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7 Atomcented 0.8 0.636 0.563 0.82 H050, O058, N069, C006, C039, 
C037, O056, C001, N073, C034, 
C043, C044, C007, C033, C017, 
H052, C024, C003, C025, H048, 
F084 
8 Geometrical 0.73 0.537 0.465 0.907 MAXDP, GN..O, GO..S, TIE, 
GN..N, GN..S, MAXDN, GN..F, 
FDI, SPAM, W3D, H3D, J3D, 
ASP, GO..O, DELS, LBw 
9 Charged 0.63 0.392 0.351 0.1 RNCG, PCWTe, Qmean, RPCG, 
LDip, qpos, Qtot, TE2 
10 Functional d. 0.75 0.568 0.496 0.881 nCaR, nHDon, nRSR, 
nCONHRPh, nCOPh, nNH2Ph, 
nNHR, nCN, nCs, nCq, nNO2Ph, 
nHAcc, nRORPh, nNR2Ph, nCt, 
nNN, nCNPh, nOHPh 
11 Buct desc. 0.70 0.490 0.432 0.935 BEHv3, BEHm7, BEHp7, BEHv4, 
BEHp8, BEHm8, BEHm6,BEHp6, 
BEHm3, BEHm1, BELv7, BELe8, 
BELm7 
12 galvezted 0.56 0.316 0.275 1.056 GGI5, GGI3, JGI2, JGI4, JGI6, 
JGT, JGI1 
13 getaway 0.86 0.741 0.698 0.682 R1P, R4u, H8v, R5m-A, R3e, 
HATS4m, R4m, R6m-A, R7u-A, 
H6u, HATS7u, R4v,HATS4u,H2e, 
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H2m, HATS4v, R1u, R5u-A. 
14 RDF desc. 0.82 0.679 0.625 0.759 RDF050m,  RDF050u, RDF010e, 
RDF030v, RDF125m, RDF100u, 
RDF135e, RDF060m, RDF025m, 
RDF140m, RDF130m, RDF075m, 
RDF020m, RDF020u, RDF020v, 
RDF105u, RDF025u, RDF155v 
15 Topological 0.78 0.610 0.566 0.818 X4Av, TIC1, LP1, RDSUM, 
X0Av, SIC1, ISIZ, CIC4, IDDE, 
SEigZ, SIC2, DDr03, X2v 
16 Whem. 0.75 0.569 0.483 0.892 G3s, E2s, E2u, Av, P1s, E3m,E3v, 
E2v, P1e, E1s, E1e, E1u, G2u, 
G3m, G3e, G2s, G1m, G1e, G3p, 
Vs, G3u 
17 Grooup17 0.6 0.357 0.319 1.024  Surface Area (Approx), total, 
EPH, Dmy, Log P, 
HydrationEnergy, Polarizability 
 
No. refers to group number, R refers to correlation coefficient, (R2) refers to 
coefficient of determination, R2adj. refers to adjusted R2 , and selected descriptors  
refer to descriptors chosen by the last MLR model. 
Then we made an excel file containing the descriptors of the last model of each group 
of the 17 groups and also Log 1/Ki. We performed the final MLR analysis using SPSS 
software by the stepwise regression method, where log1/Ki is the dependent variable 
and all descriptors in this file are the independent variables. The results of this final 
MLR are summarized in table (3.2). 
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Table (3.2): Final MLR model summary. 
 
  
Selected descriptorsR2adj.R2RNumber of
descriptors 
Model
Number
R1p+ 0.2790.2850.5341 1 
R1p+,  R4u 0.3730.3830.6192 2 
R1p+,  R4u,  H8v            0.4540.4670.6843 3 
R1p+,  R4u,  H8v, RDF010e           0.520.5350.7314 4 
R1p+, R4u, H8v, RDF010e,         
C006 
0.5720.5890.7675 5 
R1p+,R4u , H8v ,RDF010e , 
C006 ,O058 
0.60.6190.7876 6 
R1p+,R4u, H8v, RDF010, C006, 
O-058, O-056 
0.6350.6560.817 7 
R1p+, R4u, H8v, RDF010e,C006, 
O-058, O-056, R7u 
0.6650.6860.8288 8 
R1p+, R4u, H8v, RDF010e, 
C006, O-058, O-056, R7u, Logp 
0.690.7120.8449 9 
R1p+,R4u, H8v, RDF010e, C006 
,O-058 ,O-056 ,R7u, Logp , 
Mor10m 
0.7150.7370.85910 10 
R1p+, R4u,  H8v,  RDF010e, 
C006 , O-058 ,O-056 ,R7u, Logp 
,Mor10m ,RDF130m 
0.7350.760.87211 11 
 
The following equation represents the best MLR model: 
Log 1/Ki   = 13.443  (±1.450)  –  0.376  (±0.108)  ×C006  –  31.230 (±5.216) ×R1p – 4.665    
(±0.539) × R4u –5.871 (±0.905) × H8v + 0.341 (±0.058) × RDF010e      + 0.758   
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(±0.103)  × O058 + 0.466 (±0.145) × O056 + 15.911 (±3.928) × R7u + 0.257 
(±0.055) × Log P   +0.697 (±0.156) × Mor10m – 0.110(±0.033) × RDF130m. 
 
                    N = 127         R2   =0.76 
A brief description of the descriptors of the best MLR model: 
      C006 reflects CH2   constitutional groups number, O-058 reflects number of 
ketones constitutional groups, O-056 reflects number of alcohols constitutional 
groups, Mor10m and RDF130m gives informations about atomic masses, RDF010e 
reflects the elecronegativity,  Log p: Octanol water partition coefficient reflects the 
hydrophobicity . These descriptors have small coefficients and so small contribution 
of the activity. 
The following four descriptors have larger contribution in  calculating the activity, 
these descriptors are: R1p, R7u, H8v, and R4u. They belong to the Getaway dragon 
descriptors. Getaway descriptors calculated from the leverage matrix obtained by the 
centered atomic coordinates (molecular influence matrix, MIM). H subdivision 
descriptors (H8v) are 3D-autocorrelation descriptors obtained from MIM; R and R+ 
descriptors are analogously obtained from the leverage/geometry matrix. The most 
important descriptor in this equation is R1p which reflects the polarizability of the 
compounds. Accordining to the above equation polarizability is proportional to the 
activity. The second important descriptor is R7u which reflects the geometrical matrix 
of the compound. R7u descriptor value is inversely proportional to the activity too.  
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We picked models with R2>0.6 [23], so we applied LOO and LMO cross validation 
on models 6 to 11. The results of LOO and LMO cross validation are summarized in 
tables (3.3) and (3.4) respectively. 
  
Table (3.3): LOO cross validation results. 
 
RSEP  PSE PRESS/SST  R2cv SST SPRESS PRESS no.desc. model 
8.749 0.7629 0.6166 0.3834 119.8863 0.7848 73.9166 6 6 
8.3143 0.725 0.5254 0.4746 127.0507 0.749 66.7524 7 7 
7.9395 0.6923 0.4579 0.5421 132.9324 0.7182 60.8705 8 8 
7.5998 0.6627 0.4041 0.5959 138.0304 0.6904 55.7726 9 9 
7.2608 0.6331 0.3563 0.6437 142.8951 0.6625 50.9079 10 10 
6.9335 0.6046 0.315 0.685 147.3802 0.6354 46.4227 11 11 
 
Table (3.4): LMO cross validation results 
  
RSEP PSE PRESS/SST R2cvSSTSPRESSPRESS model 
8.863 0.7645 0.6248 0.3752 118.7814 0.7864 74.2184 6 
8.0361 0.6931 0.484 0.516 126.0597 0.7161 61.0156 7 
7.7686 0.6701 0.424 0.576 134.4704 0.6951 57.0211 8 
7.9048 0.6818 0.4126 0.5874 143.0864 0.7104 59.0383 9 
7.8286 0.6752 0.3882 0.6118 149.1469 0.7065 57.9054 10 
7.3851 0.637 0.326 0.674 158.0673 0.6694 51.5305 11 
  
  
PRESS (predictive residual sum of squares) which is a standard index to measure the 
accuracy of the model. It is also called SSE (error sum of squares), SST (total sum of 
squares), R2cv or Q2 (cross-validated correlation coefficient), SPRESS (uncertainty of 
prediction), PSE (Predictive Square Errors) and also called RMSE (root mean square 
error), and RSEP is relative standard error of prediction. 
We found that models 8, 9, 10, and 11 can be used as ANN input. Because they have 
the best predictivity and the best cross validation results .These models have the 
highest values of R2, R2cv, and the lowest values of PSE. The following figures show 
the relation between R2cv and PSE with model number as shown in figures (3.1) and 
(3.2) respectively. 
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Figure (3.1): The relation between R2cv and model number for LOO and LMO cross 
validation. 
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Figure (3.2): The relation between PSE and model number for LOO and LMO cross 
validation. 
Before running ANN we divided the data into two sets, training and test sets. We used 
MATLAB software to perform PCA for descriptors chosen by the model and activity 
expressed as log 1/Ki. The result is shown in figure (3.3). The two sets of data must 
express all zones of the distribution.  
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Figure (3.3): Correlation between first and second principal components. 
According to the above PCA figure, two compounds SD146 and XP521 were 
classified as outliers and removed from the two sets. Outliers are compounds that lie 
away from the clusters and behave biologically in a different manner. 
The divided data without the outliers are used as input to ANN. We have four models; 
the number of hidden nodes at this stage was 6 hidden nodes. Results of this stage 
with their LOO cross validation are summarized in table (3.5), as well as figures (3.4) 
and (3.5). 
Table (3.5): Coefficients of determination and cross validation results for models 8-11 
by ANN method.  
Test set Training set 
Model 
number 
R2 
 
R2cv 
 
PRESS PSE R2 R2cv 
 
PRESS PSE 
8 0.8 0.7478 7.9227 0.5520 0.693 0.5504 45.8130 0.6803 
9 0.763 0.6855 9.36 0.6000 0.757 0.6569 36.3436 0.6059 
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10 0.772 0.7601 9.6705 0.6099 0.796 0.7335 30.7773 0.5576 
11 0.776 0.7401 9.2043 0.5950 0.768 0.6884 34.4796 0.5902 
. 
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Figure (3.4): R2cv values for training and test set compounds against model number.  
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Figure (3.5): PSE values for training and test set compounds against model number. 
Figures (3.4), (3.5) and table (3.5) show that models 8 and 10 have the best coefficient 
of determination and cross validation values. We optimized number of hidden nodes 
for these two models. We used different number of hidden nodes starting from 2 to 
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20. The results of hidden nodes optimization for models 8 and 10 are summarized in 
table (3.6), table (3.7), and figures (3.6), (3.7), (3.8), (3.9). 
 
Table (3.6): Results of optimizing number of hidden nodes as well as cross validation 
for model 8. 
Training set Test set 
PSE  R2cv R2 PSE R2cv R2 
Number of 
hidden 
nodes 
0.72240.4954 0.6564 0.5530 0.7575 0.7559 2 
0.69600.5347 0.6786 0.5526 0.7550 0.7964 3 
0.70650.5264 0.6687 0.5728 0.7268 0.781 4 
0.73340.5132 0.6456 0.5556 0.7747 0.7994 5 
0.67450.5978 0.6989 0.5831 0.7705 0.7846 6 
0.68550.5357 0.6878 0.5778 0.6921 0.7773 7 
0.61890.6578 0.7455  0.6319 0.7014 0.7432 8 
0.65160.5915 0.7194 0.5818 0.7024 0.7733 9 
0.68130.5623 0.6918 0.5664 0.7237 0.7857 10 
0.69770.5493 0.6815 0.5807 0.7045 0.7746 11 
0.64280.6031 0.727 0.5991 0.6902 0.762 12 
0.69020.5456 0.6835 0.5647 0.7428 0.7874 13 
0.65460.5900 0.7157 0.5420 0.7515 0.8038 14 
0.64430.6187 0.7242 0.6056 0.6728 0.7556 15 
0.62910.6533 0.7418  0.6438 0.6981 0.7335 16 
0.68850.5665 0.6856 0.5761 0.7485 0.7855 17 
0.65760.6191 0.7149  0.6644 0.7062 0.728 18 
0.68540.5553 0.6891 0.5734 0.7216 0.7822 19 
0.65270.6109 0.7194 0.5247 0.8104 0.8258 20 
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 Figure (3.6): R2 and R2cv values for test and training sets compounds against number 
of hidden nodes for model 8. 
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Figure (3.7): PSE values for test and training sets compounds against number of 
hidden nodes for model 8. 
 
Table (3.7): Results of optimizing number of hidden nodes as well as cross validation 
for model 10. 
  
Training setTest set
PSE  R2cv R2 PSE R2cv R2 
Number 
of hidden 
nodes 
0.65220.6026 0.718 0.6290 0.7277 0.75 2 
0.61040.6698 0.753 0.6427 0.7057 0.736 3 
0.59140.6922 0.769 0.6680 0.7148 0.73 4 
0.60480.6701 0.757 0.6641 0.7081 0.734 5 
0.60650.6748 0.756 0.6439 0.7316 0.75 6 
0.58410.7001 0.774 0.6743 0.6936 0.719 7 
0.55200.7337 0.799 0.6856 0.6892 0.714 8 
0.57580.7100 0.779 0.6215 0.7624 0.773 9 
0.59290.6915 0.77 0.6101 0.7606 0.771 10 
0.59590.6831 0.765 0.6212 0.7264 0.752 11 
0.60430.6792 0.761 0.6524 0.7320 0.743 12 
0.51490.7816 0.825 0.7249 0.6915 0.708 13 
0.59020.6799 0.771 0.5882 0.7614 0.779 14 
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0.58290.6983 0.774 0.5844 0.7741 0.786 15 
0.60590.6775 0.756 0.5259 0.8174 0.827 16 
0.52920.7562 0.816 0.5571 0.7778 0.797 17 
0.60950.6603 0.753 0.6032 0.7495 0.768 18 
0.68350.5442 0.69 0.5502 0.7790 0.802 19 
0.66040.5794 0.71 0.6016 0.7766 0.786 20 
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Figure (3.8): R2 and R2cv values against number of hidden nodes for model 10. 
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Figure (3.9): PSE values of the test and training sets compounds against number of 
hidden nodes for model 10.  
  
 Table (3.6) that summarize results of model 8 shows that the ANN model with 8 
hidden nodes is the best model because it has the best cross validation results. This 
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model has closed coefficient of determination for the training and test set (0.7455) and 
(0.7432) which indicates that this model is very predictive. Also this model has the 
best cross validation results if we look at the two sets at same time. If the results of 
the cross validation are very closed we prefer results of less hidden nodes as shown in 
figures (3.6) and (3.7). 
Table (3.7) that summarize results of model 10 shows that the ANN model with 6 
hidden nodes is the best model because it has the best cross validation results. This 
model has closed coefficients of determination for the training and test set (0.756) and 
(0.75) which indicates this model is very predictive. Also coefficient of determination 
for that model is closed to the cross validation coefficients of determination as shown 
in figure (3.8). 
Table (3.8): Shows observed and predicted activities expressed as log 1/Ki for model 
10 with 6 hidden nodes and model 8 with 8 hidden nodes for test set compounds. 
 
Table (3.8): Observed and predicted activities expressed as log 1/Ki for model 10 with 
6 hidden nodes and model 8 with 8 hidden nodes for test set compounds. 
Predicted activity: 
model 10 with 6 
hidden nodes  
Predicted activity:  
model 8 with 8 
hidden nodes 
Observed activity 
Compound 
number 
6.81 7.98 8.08 10 
9.47 9.97 9.73 103 
10.82 10.20 10.46 110 
9.53 10.21 9.62 43 
8.40 8.55 7.89 32 
10.17 10.03 10.57 100 
8.37 8.80 8.54 33 
8.94 8.34 9.33 41 
9.71 9.60 9.77 104 
9.99 9.99 10.29 105 
9.92 9.64 8.19 106 
8.04 7.69 8.37 19 
8.40 8.30 8.77 86 
8.84 8.57 8.07 16 
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5.48 5.82 5.96 5 
8.32 8.37 8.68 50 
7.41 8.25 8.29 45 
8.34 8.13 8.47 1 
8.70 8.41 7.86 69 
7.55 7.07 8.43 72 
7.35 7.07 7.58 82 
6.92 7.02 6.9 83 
9.33 9.89 9.96 125 
9.84 9.85 10.05 123 
7.58 7.62 6.47 63 
10.18 9.48 10.44 93 
 
Figures (3.10) and (3.11) show regression between predicted and observed activities 
for model 8 with 8 hidden nodes for training and test set compounds respectively. 
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 Figure (3.10): Predicted against observed activity for model 8 with 8 hidden nodes 
for training set compounds. 
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Figure (3.11): Predicted against observed activity for model 8 with 8 hidden nodes for 
test set compounds. 
 
Figures (3.12) and (3.13) show regression between predicted and observed activities 
for model 10 with 6 hidden nodes for training and test set compounds respectively.  
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Figure (3.12): Predicted against observed activity for model 10 with 6 hidden nodes 
for training set compounds. 
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Figure (3.13): Predicted against observed activity for model 10 with 6 hidden nodes 
for test set compounds.  
 
Figures (3.14) and (3.15) show regression between residue and observed activities for 
model 8 with 8 hidden nodes for training and test set compounds respectively.  
 
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
5 6 7 8 9 10 11
Observed activity
R
es
id
ue
Series1
  
 
Figure (3.14): Residue values against observed activity for model 8 with 8 hidden 
nodes for training set compounds. 
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Figure (3.15): Residue values against observed activity for model 8 with 8 hidden 
nodes for test set compounds. 
 
 
Figures (3.16) and (3.17) show regression between residue values and observed 
activity for model 10 with 6 hidden nodes for training and test set compounds 
respectively. 
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Figure (3.16): Residue values against observed activity for model 10 with 6 hidden 
nodes for training set compounds. 
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Figure (3.17): Residue values against observed activity for model 10 with 6 hidden 
nodes for test set compounds. 
 
 
We perform a chance correlation test for the two ANN models. Chance correlation 
should be done using the same configuration parameters and the same activation 
functions of all our ANN models. 
 
The chance correlation was done using matlab software. The results of chance 
correlation for models 8 and 10 and their cross validation parameters are summarized 
in tables (3.9) and (3.10) respectively. 
 
Table (3.9): Chance correlation and cross validation results for model 8 with 8 hidden 
nodes. 
Training setTest set
PSE   R2cv   R2     PSE      R2cv  R2 trial 
1.1101     -5.0194     0.18591.3155     -5.9304     0.0023 1 
1.1602     -9.8836     0.10991.3981     -15.6119    0.0981 2 
1.1289     -5.2585      0.15771.1447     -8.1485     0.166 3 
1.0290     -2.4021      0.30661.5349     -4.6112     0.0444 4 
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1.0513     -2.6300      0.28471.3413     -4.4681     0.0055 5 
1.1040     -4.4439      0.21081.3212     -5.5366     0.0049 6 
1.1578     -11.8331   0.12921.3321     -27.5796    0.0812 7 
1.0637     -2.7941      0.25651.2651     -5.7272     0.0272 8 
1.1816     -18.7691    0.08221.1595     -20.9601    0.1204 9 
1.1464     -4.9351      0.13281.4233     -7.3886     0.0442 10 
 
Table (3.10): Chance correlation and cross validation results for model 10 with 6 
hidden nodes. 
    
 
After studying the results, we have very bad models after doing chance correlation 
with low R2 and bad cross validation results. This proves that we didn’t have our 
original models by chance.  
 
To check the presence of outliers in a model, we prepared an excel file with the 
observed activity and the predicted one for the training set as well the test set. Then, 
for each set, we calculated the standard deviation of the observed activity data (using 
excel). Then we calculated the residue which is equal to the difference between the 
predicted and observed one. Finally, if the value of the residue is larger than 
[2*standard deviation of the observed activity], then this point is considered 
as an outlier. We found that there was no outlier in our data. 
 
 
Training setTest set
PSE R2cv R2     PSE       R2cv    R2 trial 
1.0788      -3.3394      0.3061.3351      -6.399 8.00E-05 1 
1.1143      -4.5172      0.17741.4000     -7.3000     0.0109 2 
1.1132      -3.9964      0.17661.3919     -6.7843     0.0105 3 
1.1457      -3.4358      0.17221.4543     -5.0580     0.0055 4 
1.1542      -6.8932      0.12261.4728     -9.8387     0.1597 5 
1.0499      -1.4550      0.29331.4552     -4.7395     0.0178 6 
1.1461      -9.2500      0.13491.1966     -8.8006     0.0576 7 
1.0604      -2.7803      0.26531.2068     -3.8760     0.0786 8 
1.0727      -2.5755      0.24171.4173     -7.7662     0.0405 9 
1.0428      -0.9860      0.28251.4419     -2.4026     0.0009 10 
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Comparison With Other QSAR Studies  
Speranta, et al [5] have performed QSAR study on the same set of anti-HIV1- 
protease compounds used in this study. They have modeled the HIV1-protease 
inhibitor activity (log 1/Ki) from different families using Comparative Molecular 
Field Analysis (CoMFA) methodology. They found that no simple or multiple 
regressions gave any statistically significant model. A cross validation determination 
coefficient (R2cv) of 0.63 and coefficient of determination R2 of  (0.70) were obtained. 
 
 Khedkar, et al [24] used comparative molecular field analysis (CoMFA) and 
comparative molecular similarity indices analysis (CoMSIA) to build QSAR models 
for 54 compounds out of 127 compounds used in our study . Two different alignment 
schemes viz. receptor-based and atom-fit alignment, were used in this study to build 
the QSAR models. The R2cv  for CoMFA and CoMSIA derived from receptor-based 
alignment was 0.68 and 0.65 respectively. Although these results seems to be good 
but they are not promising because it was done on one group of  compounds that have 
the same core and not many families of anti-HIV1 protease compounds like what we 
did in our study. 
The regression models obtained in our study are very promising when considering the 
nature of the heterogeneous data set. The PC-ANN approach used succeeds to explain 
the non-linear relationships for the data of interest, while the multilinear regression 
analysis fails to model the data set as one group. 
In our study we calculated different groups of descriptors for all compounds and 
treated them separately and then the best among them treated together as one group, 
then we tried to build a predictive model using SPSS software. The best MLR R2cv 
value obtained was (0.644) with R2 = (0.737). 
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  When we performed PCA we had two outliers and we didn’t use them in 
calculations. Then we used MBP software to build nonlinear models. The best R2cv 
values obtained were (0.701) and (0.732) for the test sets of model 8 with 8 hidden 
nodes and model 10 with 6 hidden nodes respectively.  We believed that our models  
are predictive because we had good cross validation results. 
Although our results seems to be close to Separanta  and Khedkar results, our models 
are more predictive because we used more compounds with different core structures 
in our data, also we calculated a wider range of descriptors.  
Our results submitted for publication to CBDD [25]. 
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In this research we built the structure of 127 compounds using Hyperchem software. 
These compounds were optimized using AM1 semi-imperical method. To study the 
anti-HIV activity, we calculated different groups of descriptors, some descriptors 
were calculated using Hyperchem software and others were calculated using Dragon 
software. 
 
The multilinear QSAR equations were obtained by SPSS software using stepwise 
method. Four multilinear equations with good statistical qualities and predictive 
power were obtained. These four MLR models are used as input for the PC-ANN 
modeling and the best two of ANN models are used for hidden nodes optimization. 
The PC-ANN models give better predictive ability and better cross validation results . 
This is because the relation between the activity and the structure is more complex to 
be expressed as a linear relation. Generally, PC-ANN provides promising improved 
models for heterogeneous data sets without splitting them into categories. The PC-
ANN gives better regression models with good prediction ability. 
The following four descriptors have larger contribution in calculating the 
inhibition activity, these descriptors are: R1p, R7u, H8v, and R4u. They belong to the 
Getaway dragon descriptors. Getaway descriptors calculated from the leverage matrix 
obtained by the centered atomic coordinates (molecular influence matrix, MIM). H 
subdivision descriptors (H8v) are 3D-autocorrelation descriptors obtained from MIM; 
R and R+ descriptors are analogously obtained from the leverage/geometry matrix. 
The most important descriptor is R1p which reflects the polarizability of the 
compounds. Polarizability is proportional to the activity. The second important 
descriptor is R7u which reflects the geometrical matrix of the compound. R7u 
descriptor value is inversely proportional to the activity too.              
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